PulseSight Therapeutics SAS, an ophthalmology biotech company developing disruptive non-viral vectorized therapies with minimally-invasive delivery technology, today announces the first close of its ...

Macular degeneration is a condition that affects the retina, which is neural tissue that lines the back of the eye, like wallpaper in a room. There is an important area ...

Age-related macular degeneration is the leading cause of vision loss in those who are age 50 or older. In fact, almost 20 million people in the U.S. have some type of age-related macular ...

Smoking damages the blood vessels in the eyes, which over time increases the risk for several complications, including ...

This fluid buildup leads to retinal swelling, which can cause blurred ... phase III pivotal trials in wet AMD, dubbed LUGANO and LUCIA. Wet age-related macular degeneration (wet AMD) is a major ...

Macular degeneration is a leading cause of vision loss for people over 50, but there are ways to help protect your eyesight.

Macular degeneration is an incurable eye condition that affects the retina. It comes in two forms: wet and dry. Generally, medications can help with age-related macular degeneration, or AMD.

The Macular Society has described the Medicines and Healthcare products Regulatory Agency’s (MHRA) decision to reject a treatment for late-stage dry AMD as “undoubtedly disappointing news.” ...

Dry macular degeneration is a common eye disorder among people aged above 50 years. It causes blurred or reduced central vision due to thinning of the macula. The macula is the part of the retina ...

Dry macular degeneration is a common eye disorder ... Dry AMD typically progresses slowly, but wet AMD can cause severe visual impairment within days or weeks of onset. In the early stages of ...

Request a sample and discover the recent advances in dry AMD treatment drugs @ Dry Age-Related Macular Degeneration Pipeline ... progresses slowly, but wet AMD can cause severe visual impairment ...